Free Trial

Tristel (LON:TSTL) Stock Crosses Below 200 Day Moving Average - Here's What Happened

Tristel logo with Medical background

Tristel plc (LON:TSTL - Get Free Report) shares passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 450.21 ($5.89) and traded as low as GBX 385 ($5.04). Tristel shares last traded at GBX 388 ($5.08), with a volume of 19,698 shares trading hands.

Tristel Stock Down 2.1 %

The stock has a market capitalization of £181.07 million, a P/E ratio of 2,969.23 and a beta of 0.23. The company has a current ratio of 4.92, a quick ratio of 3.83 and a debt-to-equity ratio of 19.12. The stock's 50 day simple moving average is GBX 446.69 and its 200 day simple moving average is GBX 450.21.

Insider Activity

In other Tristel news, insider Elizabeth Dixon sold 50,000 shares of the stock in a transaction that occurred on Thursday, September 19th. The stock was sold at an average price of GBX 397 ($5.20), for a total transaction of £198,500 ($259,782.75). Company insiders own 4.89% of the company's stock.

Tristel Company Profile

(Get Free Report)

Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers medical instrument disinfection products, including airway management, cardiology, ear, nose and throat, endoscopy, gastrointestinal physiology, laboratory, ophthalmology, phlebotomy, reproductive health/IVF, surface, ultrasound, urology, women's health, and other products under the Tristel brand.

Featured Stories

Should you invest $1,000 in Tristel right now?

Before you consider Tristel, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tristel wasn't on the list.

While Tristel currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Energy Vault’s 100% Stock Jump: CEO Discusses $350M Project in Australia in MarketBeat CEO Series
Market Shifts After Election: What Stocks Could Benefit Most?
Post-Election Chaos or Opportunity? Prepare Your Investments

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines